Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone.
Click here for original story, Medication keeps more patients with ANCA-associated vasculitis in remission than steroids
Source: ScienceDaily